Page last updated: 2024-10-29

iotrolan and Chronic Disease

iotrolan has been researched along with Chronic Disease in 1 studies

iotrolan: nonionic, isotonic contrast medium designed for intrathecal use; RN given refers to cpd without isomeric designation; DL-3-117 refers to stereoisomer; structure given in first source

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hartwig, CH1
Braunschweig, R1
Böhm, P1
Cormann, PL1

Other Studies

1 other study available for iotrolan and Chronic Disease

ArticleYear
[Double-contrast arthro-CT in diagnosis of shoulder instability].
    Sportverletzung Sportschaden : Organ der Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin, 1995, Volume: 9, Issue:1

    Topics: Adult; Athletic Injuries; Bone Transplantation; Chronic Disease; Contrast Media; Female; Humans; Joi

1995